OPTH — Optimi Health Corp.
$3.25-0.91%
Last close: · regular session
Last 21 sessions
OPTH closed at $3.25 (-0.91%) on Oct 23, 2026. Float: 4.8M shares. Latest SEC filing: 6-K on Oct 26, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for OPTH in the TickerWise workspace.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Company profile
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: CA
- Exchange: NASDAQ Capital Market
- Employees: 10
- Website: https://www.optimihealth.ca
Latest SEC filings for OPTH
Latest OPTH news
- Optimi Health to Present at the ThinkEquity Conference Read article
- Optimi Health Appoints Melanie Pump to Board of Directors Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.